Literature DB >> 27416980

The Ethics of Deprescribing in Older Adults.

Emily Reeve1, Petra Denig2, Sarah N Hilmer3, Ruud Ter Meulen4.   

Abstract

Deprescribing is the term used to describe the process of withdrawal of an inappropriate medication supervised by a clinician. This article presents a discussion of how the Four Principles of biomedical ethics (beneficence, non-maleficence, autonomy, and justice) that may guide medical practitioners' prescribing practices apply to deprescribing medications in older adults. The view of deprescribing as an act creates stronger moral duties than if viewed as an omission. This may explain the fear of negative outcomes which has been reported by prescribers as a barrier to deprescribing. Respecting the autonomy of older adults is complex as they may not wish to be active in the decision-making process; they may also have reduced cognitive function and family members may therefore have to step in as surrogate decision-makers. Informed consent is intended as a process of information giving and reflection, where consent can be withdrawn at any time. However, people are rarely updated on the altered risks and benefits of their long-term medications as they age. Cessation of inappropriate medication use has a large financial benefit to the individual and the community. However, the principle of justice also dictates equal rights to treatment regardless of age.

Entities:  

Keywords:  Bioethics; Deprescribing; Elderly; Inappropriate medication use; Medication withdrawal; Principlism

Mesh:

Year:  2016        PMID: 27416980     DOI: 10.1007/s11673-016-9736-y

Source DB:  PubMed          Journal:  J Bioeth Inq        ISSN: 1176-7529            Impact factor:   1.352


  63 in total

1.  Postmarketing surveillance and adverse drug reactions: current perspectives and future needs.

Authors:  T Brewer; G A Colditz
Journal:  JAMA       Date:  1999-03-03       Impact factor: 56.272

2.  Active and passive euthanasia.

Authors:  J Rachels
Journal:  N Engl J Med       Date:  1975-01-09       Impact factor: 91.245

Review 3.  Casuistry and principlism: the convergence of method in biomedical ethics.

Authors:  M Kuczewski
Journal:  Theor Med Bioeth       Date:  1998-12

4.  People's attitudes, beliefs, and experiences regarding polypharmacy and willingness to Deprescribe.

Authors:  Emily Reeve; Michael D Wiese; Ivanka Hendrix; Michael S Roberts; Sepehr Shakib
Journal:  J Am Geriatr Soc       Date:  2013-08-26       Impact factor: 5.562

Review 5.  Alterations in drug disposition in older adults.

Authors:  Emily Reeve; Michael D Wiese; Arduino A Mangoni
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-01-19       Impact factor: 4.481

6.  For how long should we use symptomatic therapies to treat people with Alzheimer disease?

Authors:  Kenneth Rockwood
Journal:  Can J Psychiatry       Date:  2014-12       Impact factor: 4.356

7.  Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes.

Authors:  Danijela Gnjidic; Sarah N Hilmer; Fiona M Blyth; Vasi Naganathan; Louise Waite; Markus J Seibel; Andrew J McLachlan; Robert G Cumming; David J Handelsman; David G Le Couteur
Journal:  J Clin Epidemiol       Date:  2012-06-27       Impact factor: 6.437

8.  Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly.

Authors:  Alex Z Fu; Jenny Z Jiang; Jaxk H Reeves; Jack E Fincham; Gordon G Liu; Matthew Perri
Journal:  Med Care       Date:  2007-05       Impact factor: 2.983

9.  Practical problems with medication use that older people experience: a qualitative study.

Authors:  Kim Notenboom; Erna Beers; Diana A van Riet-Nales; Toine C G Egberts; Hubert G M Leufkens; Paul A F Jansen; Marcel L Bouvy
Journal:  J Am Geriatr Soc       Date:  2014-12       Impact factor: 5.562

10.  Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes.

Authors:  Emma C Davies; Christopher F Green; Stephen Taylor; Paula R Williamson; David R Mottram; Munir Pirmohamed
Journal:  PLoS One       Date:  2009-02-11       Impact factor: 3.240

View more
  11 in total

1.  Which Lane Should We Be In?

Authors:  Michael A Ashby; Leigh E Rich
Journal:  J Bioeth Inq       Date:  2016-10-31       Impact factor: 1.352

2.  Poly-de-prescribing to treat polypharmacy: efficacy and safety.

Authors:  Doron Garfinkel
Journal:  Ther Adv Drug Saf       Date:  2017-10-27

3.  The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people.

Authors:  Adam Todd; Jesse Jansen; Jim Colvin; Andrew J McLachlan
Journal:  BMC Geriatr       Date:  2018-11-29       Impact factor: 3.921

4.  Health professionals' and researchers' opinions on conducting clinical deprescribing trials.

Authors:  Alexander J Clough; Sarah N Hilmer; Lisa Kouladjian-O'Donnell; Sharon L Naismith; Danijela Gnjidic
Journal:  Pharmacol Res Perspect       Date:  2019-04-25

5.  Deprescribing medications for older adults in the primary care context: A mixed studies review.

Authors:  Robyn J Gillespie; Lindsey Harrison; Judy Mullan
Journal:  Health Sci Rep       Date:  2018-05-10

6.  How many older adults receive drugs of questionable clinical benefit near the end of life? A cohort study.

Authors:  Lucas Morin; Jonas W Wastesson; Marie-Laure Laroche; Johan Fastbom; Kristina Johnell
Journal:  Palliat Med       Date:  2019-06-07       Impact factor: 4.762

7.  Barriers and Facilitators of Conducting Medication Reviews in Nursing Home Residents: A Qualitative Study.

Authors:  Hans Wouters; Juliet M Foster; Anne Ensink; Lisa Kouladjian O'Donnell; Sytse U Zuidema; Froukje Boersma; Katja Taxis
Journal:  Front Pharmacol       Date:  2019-09-18       Impact factor: 5.810

8.  Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus.

Authors:  Lucas Morin; Marie-Laure Laroche; Davide L Vetrano; Johan Fastbom; Kristina Johnell
Journal:  Eur J Clin Pharmacol       Date:  2018-06-23       Impact factor: 2.953

Review 9.  Evidence for deprescription in primary care through an umbrella review.

Authors:  Antonio Olry de Labry Lima; Jorge Marcos Marcos; Alfonso Marquina Marquez; María de Los Ángeles González Vera; Antonio Matas Hoces; Clara Bermúdez Tamayo
Journal:  BMC Fam Pract       Date:  2020-06-08       Impact factor: 2.497

Review 10.  Patient harm from cardiovascular medications.

Authors:  Chariclia Paradissis; Neil Cottrell; Ian Coombes; Ian Scott; William Wang; Michael Barras
Journal:  Ther Adv Drug Saf       Date:  2021-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.